Home > News > MDA Awards Largest Private Company Grant to Asklepios
July 22nd, 2004
MDA Awards Largest Private Company Grant to Asklepios
Abstract:
Asklepios, a startup biotechnology firm focused on delivery of gene therapies, has received a $1.6 million grant from the Muscular Dystrophy Association to pursue possible gene therapies to treat muscular dystrophy. Asklepios describes itself as a company focused on the disease therapies delivered to genes through the design of proprietary biological nano particles.
Source:
LocalTechWire.com
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||